Loading…

Characterization of Asymptomatic Bacteriuria Escherichia coli Isolates in Search of Alternative Strains for Efficient Bacterial Interference against Uropathogens

Asymptomatic bacterial colonization of the urinary bladder (asymptomatic bacteriuria, ABU) can prevent bladder colonization by uropathogens and thus symptomatic urinary tract infection (UTI). Deliberate bladder colonization with ABU isolate 83972 has been shown to outcompete uropathogens and prevent...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in microbiology 2018-02, Vol.9, p.214-214
Main Authors: Stork, Christoph, Kovács, Beáta, Rózsai, Barnabás, Putze, Johannes, Kiel, Matthias, Dorn, Ágnes, Kovács, Judit, Melegh, Szilvia, Leimbach, Andreas, Kovács, Tamás, Schneider, György, Kerényi, Monika, Emödy, Levente, Dobrindt, Ulrich
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c462t-b22d949430a0f25ecabbda7cd6f1e45c3bd1ecfbede6d4e9657cd845336b4b0b3
cites cdi_FETCH-LOGICAL-c462t-b22d949430a0f25ecabbda7cd6f1e45c3bd1ecfbede6d4e9657cd845336b4b0b3
container_end_page 214
container_issue
container_start_page 214
container_title Frontiers in microbiology
container_volume 9
creator Stork, Christoph
Kovács, Beáta
Rózsai, Barnabás
Putze, Johannes
Kiel, Matthias
Dorn, Ágnes
Kovács, Judit
Melegh, Szilvia
Leimbach, Andreas
Kovács, Tamás
Schneider, György
Kerényi, Monika
Emödy, Levente
Dobrindt, Ulrich
description Asymptomatic bacterial colonization of the urinary bladder (asymptomatic bacteriuria, ABU) can prevent bladder colonization by uropathogens and thus symptomatic urinary tract infection (UTI). Deliberate bladder colonization with ABU isolate 83972 has been shown to outcompete uropathogens and prevent symptomatic UTI by bacterial interference. Many ABU isolates evolved from uropathogenic ancestors and, although attenuated, may still be able to express virulence-associated factors. Our aim was to screen for efficient and safe candidate strains that could be used as alternatives to 83972 for preventive and therapeutic bladder colonization. To identify ABU strains with minimal virulence potential but maximal interference efficiency, we compared nine ABU isolates from diabetic patients regarding their virulence- and fitness-associated phenotypes , their virulence in a murine model of sepsis and their genome content. We identified strains in competitive growth experiments, which successfully interfere with colonization of ABU isolate 83972 or uropathogenic strain 536. Six isolates were able to outcompete 83972 and two of them also outcompeted UPEC 536 during growth in urine. Superior competitiveness was not simply a result of better growth abilities in urine, but seems also to involve expression of antagonistic factors. Competitiveness in urine did not correlate with the prevalence of determinants coding for adhesins, iron uptake, toxins, and antagonistic factors. Three ABU strains (isolates 61, 106, and 123) with superior competitiveness relative to ABU model strain 83972 display low virulence in a murine sepsis model, and susceptibility to antibiotics. They belong to different phylogroups and differ in the presence of ExPEC virulence- and fitness-associated genes. Importantly, they all lack marked cytotoxic activity and exhibit a high LD50 value in the sepsis model. These strains represent promising candidates for a more detailed assessment of relevant fitness traits in urine and their suitability for therapeutic bladder colonization.
doi_str_mv 10.3389/fmicb.2018.00214
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_fee0cc4d16c04f879b8f8b005e796899</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_fee0cc4d16c04f879b8f8b005e796899</doaj_id><sourcerecordid>2009567212</sourcerecordid><originalsourceid>FETCH-LOGICAL-c462t-b22d949430a0f25ecabbda7cd6f1e45c3bd1ecfbede6d4e9657cd845336b4b0b3</originalsourceid><addsrcrecordid>eNpVUsFuGyEQXVWtmijNvaeKYy92gGUxXCqllttYitRDGqk3BOzgJdoFF3Ck5G_6p8V2EiUc4Glm3hsGXtN8JnjetkJeuMlbM6eYiDnGlLB3zSnhnM1aTP-8f4VPmvOc73BdDNO6f2xOqGSSiE6cNv-Wg07aFkj-URcfA4oOXeaHaVviVAMWfT9md8lrtMp2qNgOFds4erTOcdQFMvIB3YBOdjjwx8oIlX0P6KYk7UNGLia0cs5bD6E8i-oRrUMFDhIEC0hv9rUF3aa41WWIGwj5U_PB6THD-dN51tz-WP1eXs2uf_1cLy-vZ5ZxWmaG0r5OxVqssaMdWG1Mrxe2544A62xregLWGeiB9wwk72pOsK5tuWEGm_asWR91-6jv1Db5SacHFbVXh0BMG6VTfZARlAPA1rKecIuZEwtphBMG4w4Wkgspq9a3o9Z2ZybobR056fGN6NtM8IPaxHvVCbLAEleBr08CKf7dQS5q8tnCOOoAcZdV_UfZ8QUltJbiY6lNMecE7qUNwWpvFHUwitobRR2MUilfXl_vhfBsi_Y_V1nAmw</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2009567212</pqid></control><display><type>article</type><title>Characterization of Asymptomatic Bacteriuria Escherichia coli Isolates in Search of Alternative Strains for Efficient Bacterial Interference against Uropathogens</title><source>PubMed (Medline)</source><creator>Stork, Christoph ; Kovács, Beáta ; Rózsai, Barnabás ; Putze, Johannes ; Kiel, Matthias ; Dorn, Ágnes ; Kovács, Judit ; Melegh, Szilvia ; Leimbach, Andreas ; Kovács, Tamás ; Schneider, György ; Kerényi, Monika ; Emödy, Levente ; Dobrindt, Ulrich</creator><creatorcontrib>Stork, Christoph ; Kovács, Beáta ; Rózsai, Barnabás ; Putze, Johannes ; Kiel, Matthias ; Dorn, Ágnes ; Kovács, Judit ; Melegh, Szilvia ; Leimbach, Andreas ; Kovács, Tamás ; Schneider, György ; Kerényi, Monika ; Emödy, Levente ; Dobrindt, Ulrich</creatorcontrib><description>Asymptomatic bacterial colonization of the urinary bladder (asymptomatic bacteriuria, ABU) can prevent bladder colonization by uropathogens and thus symptomatic urinary tract infection (UTI). Deliberate bladder colonization with ABU isolate 83972 has been shown to outcompete uropathogens and prevent symptomatic UTI by bacterial interference. Many ABU isolates evolved from uropathogenic ancestors and, although attenuated, may still be able to express virulence-associated factors. Our aim was to screen for efficient and safe candidate strains that could be used as alternatives to 83972 for preventive and therapeutic bladder colonization. To identify ABU strains with minimal virulence potential but maximal interference efficiency, we compared nine ABU isolates from diabetic patients regarding their virulence- and fitness-associated phenotypes , their virulence in a murine model of sepsis and their genome content. We identified strains in competitive growth experiments, which successfully interfere with colonization of ABU isolate 83972 or uropathogenic strain 536. Six isolates were able to outcompete 83972 and two of them also outcompeted UPEC 536 during growth in urine. Superior competitiveness was not simply a result of better growth abilities in urine, but seems also to involve expression of antagonistic factors. Competitiveness in urine did not correlate with the prevalence of determinants coding for adhesins, iron uptake, toxins, and antagonistic factors. Three ABU strains (isolates 61, 106, and 123) with superior competitiveness relative to ABU model strain 83972 display low virulence in a murine sepsis model, and susceptibility to antibiotics. They belong to different phylogroups and differ in the presence of ExPEC virulence- and fitness-associated genes. Importantly, they all lack marked cytotoxic activity and exhibit a high LD50 value in the sepsis model. These strains represent promising candidates for a more detailed assessment of relevant fitness traits in urine and their suitability for therapeutic bladder colonization.</description><identifier>ISSN: 1664-302X</identifier><identifier>EISSN: 1664-302X</identifier><identifier>DOI: 10.3389/fmicb.2018.00214</identifier><identifier>PMID: 29491858</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>asymptomatic bacteriuria ; bacterial interference ; comparative genomics ; competitiveness ; Escherichia coli ; Microbiology ; whole genome draft sequences</subject><ispartof>Frontiers in microbiology, 2018-02, Vol.9, p.214-214</ispartof><rights>Copyright © 2018 Stork, Kovács, Rózsai, Putze, Kiel, Dorn, Kovács, Melegh, Leimbach, Kovács, Schneider, Kerényi, Emödy and Dobrindt. 2018 Stork, Kovács, Rózsai, Putze, Kiel, Dorn, Kovács, Melegh, Leimbach, Kovács, Schneider, Kerényi, Emödy and Dobrindt</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c462t-b22d949430a0f25ecabbda7cd6f1e45c3bd1ecfbede6d4e9657cd845336b4b0b3</citedby><cites>FETCH-LOGICAL-c462t-b22d949430a0f25ecabbda7cd6f1e45c3bd1ecfbede6d4e9657cd845336b4b0b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817090/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817090/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29491858$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Stork, Christoph</creatorcontrib><creatorcontrib>Kovács, Beáta</creatorcontrib><creatorcontrib>Rózsai, Barnabás</creatorcontrib><creatorcontrib>Putze, Johannes</creatorcontrib><creatorcontrib>Kiel, Matthias</creatorcontrib><creatorcontrib>Dorn, Ágnes</creatorcontrib><creatorcontrib>Kovács, Judit</creatorcontrib><creatorcontrib>Melegh, Szilvia</creatorcontrib><creatorcontrib>Leimbach, Andreas</creatorcontrib><creatorcontrib>Kovács, Tamás</creatorcontrib><creatorcontrib>Schneider, György</creatorcontrib><creatorcontrib>Kerényi, Monika</creatorcontrib><creatorcontrib>Emödy, Levente</creatorcontrib><creatorcontrib>Dobrindt, Ulrich</creatorcontrib><title>Characterization of Asymptomatic Bacteriuria Escherichia coli Isolates in Search of Alternative Strains for Efficient Bacterial Interference against Uropathogens</title><title>Frontiers in microbiology</title><addtitle>Front Microbiol</addtitle><description>Asymptomatic bacterial colonization of the urinary bladder (asymptomatic bacteriuria, ABU) can prevent bladder colonization by uropathogens and thus symptomatic urinary tract infection (UTI). Deliberate bladder colonization with ABU isolate 83972 has been shown to outcompete uropathogens and prevent symptomatic UTI by bacterial interference. Many ABU isolates evolved from uropathogenic ancestors and, although attenuated, may still be able to express virulence-associated factors. Our aim was to screen for efficient and safe candidate strains that could be used as alternatives to 83972 for preventive and therapeutic bladder colonization. To identify ABU strains with minimal virulence potential but maximal interference efficiency, we compared nine ABU isolates from diabetic patients regarding their virulence- and fitness-associated phenotypes , their virulence in a murine model of sepsis and their genome content. We identified strains in competitive growth experiments, which successfully interfere with colonization of ABU isolate 83972 or uropathogenic strain 536. Six isolates were able to outcompete 83972 and two of them also outcompeted UPEC 536 during growth in urine. Superior competitiveness was not simply a result of better growth abilities in urine, but seems also to involve expression of antagonistic factors. Competitiveness in urine did not correlate with the prevalence of determinants coding for adhesins, iron uptake, toxins, and antagonistic factors. Three ABU strains (isolates 61, 106, and 123) with superior competitiveness relative to ABU model strain 83972 display low virulence in a murine sepsis model, and susceptibility to antibiotics. They belong to different phylogroups and differ in the presence of ExPEC virulence- and fitness-associated genes. Importantly, they all lack marked cytotoxic activity and exhibit a high LD50 value in the sepsis model. These strains represent promising candidates for a more detailed assessment of relevant fitness traits in urine and their suitability for therapeutic bladder colonization.</description><subject>asymptomatic bacteriuria</subject><subject>bacterial interference</subject><subject>comparative genomics</subject><subject>competitiveness</subject><subject>Escherichia coli</subject><subject>Microbiology</subject><subject>whole genome draft sequences</subject><issn>1664-302X</issn><issn>1664-302X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVUsFuGyEQXVWtmijNvaeKYy92gGUxXCqllttYitRDGqk3BOzgJdoFF3Ck5G_6p8V2EiUc4Glm3hsGXtN8JnjetkJeuMlbM6eYiDnGlLB3zSnhnM1aTP-8f4VPmvOc73BdDNO6f2xOqGSSiE6cNv-Wg07aFkj-URcfA4oOXeaHaVviVAMWfT9md8lrtMp2qNgOFds4erTOcdQFMvIB3YBOdjjwx8oIlX0P6KYk7UNGLia0cs5bD6E8i-oRrUMFDhIEC0hv9rUF3aa41WWIGwj5U_PB6THD-dN51tz-WP1eXs2uf_1cLy-vZ5ZxWmaG0r5OxVqssaMdWG1Mrxe2544A62xregLWGeiB9wwk72pOsK5tuWEGm_asWR91-6jv1Db5SacHFbVXh0BMG6VTfZARlAPA1rKecIuZEwtphBMG4w4Wkgspq9a3o9Z2ZybobR056fGN6NtM8IPaxHvVCbLAEleBr08CKf7dQS5q8tnCOOoAcZdV_UfZ8QUltJbiY6lNMecE7qUNwWpvFHUwitobRR2MUilfXl_vhfBsi_Y_V1nAmw</recordid><startdate>20180214</startdate><enddate>20180214</enddate><creator>Stork, Christoph</creator><creator>Kovács, Beáta</creator><creator>Rózsai, Barnabás</creator><creator>Putze, Johannes</creator><creator>Kiel, Matthias</creator><creator>Dorn, Ágnes</creator><creator>Kovács, Judit</creator><creator>Melegh, Szilvia</creator><creator>Leimbach, Andreas</creator><creator>Kovács, Tamás</creator><creator>Schneider, György</creator><creator>Kerényi, Monika</creator><creator>Emödy, Levente</creator><creator>Dobrindt, Ulrich</creator><general>Frontiers Media S.A</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20180214</creationdate><title>Characterization of Asymptomatic Bacteriuria Escherichia coli Isolates in Search of Alternative Strains for Efficient Bacterial Interference against Uropathogens</title><author>Stork, Christoph ; Kovács, Beáta ; Rózsai, Barnabás ; Putze, Johannes ; Kiel, Matthias ; Dorn, Ágnes ; Kovács, Judit ; Melegh, Szilvia ; Leimbach, Andreas ; Kovács, Tamás ; Schneider, György ; Kerényi, Monika ; Emödy, Levente ; Dobrindt, Ulrich</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c462t-b22d949430a0f25ecabbda7cd6f1e45c3bd1ecfbede6d4e9657cd845336b4b0b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>asymptomatic bacteriuria</topic><topic>bacterial interference</topic><topic>comparative genomics</topic><topic>competitiveness</topic><topic>Escherichia coli</topic><topic>Microbiology</topic><topic>whole genome draft sequences</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Stork, Christoph</creatorcontrib><creatorcontrib>Kovács, Beáta</creatorcontrib><creatorcontrib>Rózsai, Barnabás</creatorcontrib><creatorcontrib>Putze, Johannes</creatorcontrib><creatorcontrib>Kiel, Matthias</creatorcontrib><creatorcontrib>Dorn, Ágnes</creatorcontrib><creatorcontrib>Kovács, Judit</creatorcontrib><creatorcontrib>Melegh, Szilvia</creatorcontrib><creatorcontrib>Leimbach, Andreas</creatorcontrib><creatorcontrib>Kovács, Tamás</creatorcontrib><creatorcontrib>Schneider, György</creatorcontrib><creatorcontrib>Kerényi, Monika</creatorcontrib><creatorcontrib>Emödy, Levente</creatorcontrib><creatorcontrib>Dobrindt, Ulrich</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Stork, Christoph</au><au>Kovács, Beáta</au><au>Rózsai, Barnabás</au><au>Putze, Johannes</au><au>Kiel, Matthias</au><au>Dorn, Ágnes</au><au>Kovács, Judit</au><au>Melegh, Szilvia</au><au>Leimbach, Andreas</au><au>Kovács, Tamás</au><au>Schneider, György</au><au>Kerényi, Monika</au><au>Emödy, Levente</au><au>Dobrindt, Ulrich</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Characterization of Asymptomatic Bacteriuria Escherichia coli Isolates in Search of Alternative Strains for Efficient Bacterial Interference against Uropathogens</atitle><jtitle>Frontiers in microbiology</jtitle><addtitle>Front Microbiol</addtitle><date>2018-02-14</date><risdate>2018</risdate><volume>9</volume><spage>214</spage><epage>214</epage><pages>214-214</pages><issn>1664-302X</issn><eissn>1664-302X</eissn><abstract>Asymptomatic bacterial colonization of the urinary bladder (asymptomatic bacteriuria, ABU) can prevent bladder colonization by uropathogens and thus symptomatic urinary tract infection (UTI). Deliberate bladder colonization with ABU isolate 83972 has been shown to outcompete uropathogens and prevent symptomatic UTI by bacterial interference. Many ABU isolates evolved from uropathogenic ancestors and, although attenuated, may still be able to express virulence-associated factors. Our aim was to screen for efficient and safe candidate strains that could be used as alternatives to 83972 for preventive and therapeutic bladder colonization. To identify ABU strains with minimal virulence potential but maximal interference efficiency, we compared nine ABU isolates from diabetic patients regarding their virulence- and fitness-associated phenotypes , their virulence in a murine model of sepsis and their genome content. We identified strains in competitive growth experiments, which successfully interfere with colonization of ABU isolate 83972 or uropathogenic strain 536. Six isolates were able to outcompete 83972 and two of them also outcompeted UPEC 536 during growth in urine. Superior competitiveness was not simply a result of better growth abilities in urine, but seems also to involve expression of antagonistic factors. Competitiveness in urine did not correlate with the prevalence of determinants coding for adhesins, iron uptake, toxins, and antagonistic factors. Three ABU strains (isolates 61, 106, and 123) with superior competitiveness relative to ABU model strain 83972 display low virulence in a murine sepsis model, and susceptibility to antibiotics. They belong to different phylogroups and differ in the presence of ExPEC virulence- and fitness-associated genes. Importantly, they all lack marked cytotoxic activity and exhibit a high LD50 value in the sepsis model. These strains represent promising candidates for a more detailed assessment of relevant fitness traits in urine and their suitability for therapeutic bladder colonization.</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>29491858</pmid><doi>10.3389/fmicb.2018.00214</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1664-302X
ispartof Frontiers in microbiology, 2018-02, Vol.9, p.214-214
issn 1664-302X
1664-302X
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_fee0cc4d16c04f879b8f8b005e796899
source PubMed (Medline)
subjects asymptomatic bacteriuria
bacterial interference
comparative genomics
competitiveness
Escherichia coli
Microbiology
whole genome draft sequences
title Characterization of Asymptomatic Bacteriuria Escherichia coli Isolates in Search of Alternative Strains for Efficient Bacterial Interference against Uropathogens
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T15%3A21%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Characterization%20of%20Asymptomatic%20Bacteriuria%20Escherichia%20coli%20Isolates%20in%20Search%20of%20Alternative%20Strains%20for%20Efficient%20Bacterial%20Interference%20against%20Uropathogens&rft.jtitle=Frontiers%20in%20microbiology&rft.au=Stork,%20Christoph&rft.date=2018-02-14&rft.volume=9&rft.spage=214&rft.epage=214&rft.pages=214-214&rft.issn=1664-302X&rft.eissn=1664-302X&rft_id=info:doi/10.3389/fmicb.2018.00214&rft_dat=%3Cproquest_doaj_%3E2009567212%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c462t-b22d949430a0f25ecabbda7cd6f1e45c3bd1ecfbede6d4e9657cd845336b4b0b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2009567212&rft_id=info:pmid/29491858&rfr_iscdi=true